PRESS: Advanced Medical Solutions nears GBP600 million takeover - Sky

(Alliance News) - US private equity firm TA Associates Management LP is in advanced talks for a ...

Alliance News 18 April, 2026 | 10:56AM
Email Form Facebook Twitter LinkedIn RSS

(Alliance News) - US private equity firm TA Associates Management LP is in advanced talks for a GBP600 million takeover of Advanced Medical Solutions Group PLC, Sky News reported on Saturday.

The Boston, Massachusetts-based private equity firm is preparing a formal offer for the Cheshire, England-based surgical dressings company worth around 280 pence per share.

Shares in AMS Group closed up 2.9% at 228.00 pence each on Friday, giving the AIM-listed firm a market capitalisation of GBP500.7 million. The stock has risen 25% over the last 12 months.

Sky News reported that an agreed deal between TA Associates and AMS Group could be announced "within days".

One source told Sky a deal was not certain to be concluded but that serious talks had been ongoing for some time.

Last month, the company said pretax profit leapt 81% to GBP17.8 million in 2025 from GBP9.8 million the year prior.

Revenue grew 29% to GBP228.9 million from GBP177.5 million, and AMS proposed an increased final dividend of 2.01p per share, up from 1.83p a year ago, bringing the total dividend to 2.86p per share, up 10% from 2.60p.

Spokespeople for AMS Group and TA Associates both declined to comment to Sky News.

By Michael Hennessey, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2026 Alliance News Ltd. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Advanced Medical Solutions Group PLC 228.00 GBX 2.93 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2025 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures